微信公众号
证券之星APP
| 报告期 | 净资产收益率 | 同比 | 环比 | 行业排名 | 行业均值 | 行业龙头股 | 龙头股该指标值 | 查看 |
|---|---|---|---|---|---|---|---|---|
| 2024-09-30 | 0.22% | 134.38% | -60.71% | 111/160 | 4.14% | 百利天恒 | 186.1% | 行业排名> |
| 2024-06-30 | 0.56% | -49.09% | -3.45% | 107/160 | 2.6% | 百利天恒 | 186.89% | 行业排名> |
| 2024-03-31 | 0.58% | -15.94% | 109.97% | 104/160 | 2.3% | 百利天恒 | 188.56% | 行业排名> |
| 2023-12-31 | -5.82% | -521.74% | -809.38% | 123/160 | -0.96% | 小方制药 | 41.8% | 行业排名> |
| 2023-09-30 | -0.64% | -119.05% | -158.18% | 121/160 | 2.37% | 拓新药业 | 20.51% | 行业排名> |
| 2023-06-30 | 1.1% | -57.2% | 59.42% | 104/160 | 1.51% | 拓新药业 | 19.87% | 行业排名> |
| 2023-03-31 | 0.69% | -51.06% | -50% | 104/160 | 1.38% | 拓新药业 | 19.91% | 行业排名> |
| 2022-12-31 | 1.38% | 30.19% | -58.93% | 100/160 | 0.8% | 小方制药 | 55.57% | 行业排名> |
| 2022-09-30 | 3.36% | 162.5% | 30.74% | 81/160 | 2.89% | 福元医药 | 25.41% | 行业排名> |
| 2022-06-30 | 2.57% | 301.56% | 82.27% | 76/160 | 2.24% | 小方制药 | 34.81% | 行业排名> |
| 2022-03-31 | 1.41% | 45.36% | 33.02% | 74/160 | 1.61% | 退市金泰 | 10.74% | 行业排名> |
| 2021-12-31 | 1.06% | -80.26% | -17.19% | 110/160 | 0.94% | 人福医药 | 6.82% | 行业排名> |
| 2021-09-30 | 1.28% | -80.4% | 100% | 111/160 | 4.53% | 小方制药 | 71.99% | 行业排名> |
| 2021-06-30 | 0.64% | -86% | -34.02% | 115/160 | 2.99% | 汇宇制药 | 39.25% | 行业排名> |
| 2021-03-31 | 0.97% | -49.48% | -81.94% | 96/160 | 2.52% | 汇宇制药 | 28.14% | 行业排名> |
| 2020-12-31 | 5.37% | -60.83% | -17.76% | 83/160 | 3.74% | 哈三联 | 27.17% | 行业排名> |
| 2020-09-30 | 6.53% | -48.58% | 42.89% | 63/160 | 3.22% | 汇宇制药 | 55.94% | 行业排名> |
| 2020-06-30 | 4.57% | -48.88% | 138.02% | 61/160 | 4.24% | 河化股份 | 45.32% | 行业排名> |
| 2020-03-31 | 1.92% | -47.97% | -86% | 50/160 | 2.24% | 汇宇制药 | 31.9% | 行业排名> |
| 2019-12-31 | 13.71% | 20.79% | 7.95% | 35/160 | 2.78% | 誉衡药业 | 35.56% | 行业排名> |
| 2019-09-30 | 12.7% | 39.25% | 42.06% | 19/160 | 7.61% | 奥赛康 | 35% | 行业排名> |
| 2019-06-30 | 8.94% | 72.92% | 142.28% | 19/160 | 5.05% | 奥赛康 | 28.15% | 行业排名> |
| 2019-03-31 | 3.69% | 324.14% | -67.49% | 24/160 | 2.46% | 宏源药业 | 21.91% | 行业排名> |
| 2018-12-31 | 11.35% | 86.68% | 24.45% | 43/160 | 7.09% | 奥赛康 | 9.7% | 行业排名> |
| 2018-09-30 | 9.12% | 56.97% | 76.4% | 29/160 | 7.26% | 奥赛康 | 40.69% | 行业排名> |
| 2018-06-30 | 5.17% | 6.16% | 494.25% | 38/160 | 4.65% | 信立泰 | 25.93% | 行业排名> |
| 2018-03-31 | 0.87% | -63.9% | -85.69% | 84/160 | 2.55% | 昂利康 | 15.91% | 行业排名> |
| 2017-12-31 | 6.08% | -43.18% | 4.65% | 77/160 | 9.66% | 奥赛康 | 12.08% | 行业排名> |
| 2017-09-30 | 5.81% | -50.09% | 19.3% | 59/160 | 8.31% | 一品红 | 31.62% | 行业排名> |
| 2017-06-30 | 4.87% | -40.17% | 102.07% | 45/160 | 5.59% | 丽珠集团 | 49.43% | 行业排名> |
| 2017-03-31 | 2.41% | -34.69% | -77.48% | 37/160 | 2.1% | 河化股份 | 54.24% | 行业排名> |
| 2016-12-31 | 10.7% | -24.75% | -8.08% | 51/160 | 6.33% | 华东医药 | 7.2% | 行业排名> |
| 2016-09-30 | 11.64% | -13.39% | 43% | 19/160 | 5.61% | 南新制药 | 81.7% | 行业排名> |
| 2016-06-30 | 8.14% | -18.27% | 120.6% | 22/160 | 3.53% | 德展健康 | 29.5% | 行业排名> |
| 2016-03-31 | 3.69% | -25.15% | -74.05% | 20/160 | 2.65% | 贝达药业 | 16.78% | 行业排名> |
| 2015-12-31 | 14.22% | 200% | 5.8% | 35/160 | 11.35% | 河化股份 | 19.29% | 行业排名> |
| 2015-09-30 | 13.44% | 1029.41% | 34.94% | 13/160 | 7.22% | 一品红 | 58.17% | 行业排名> |
| 2015-06-30 | 9.96% | 994.51% | 102.03% | 12/160 | 4.9% | 华东医药 | 36.97% | 行业排名> |
| 2015-03-31 | 4.93% | 812.96% | 4.01% | 12/160 | 2.41% | 华东医药 | 26.63% | 行业排名> |